In-stent restenosis of superficial femoral artery: use all arrows in the quiver.
Giuseppe VadalàFabrizio CeresaFrancesco CostaAntonio BottariGiuseppe RoscitanoFrancesco PatanèAntonio MicariPublished in: Oxford medical case reports (2022)
In-stent restenosis (ISR) is a common superficial femoral artery (SFA) stenting complication, occurring in more than one third of patients within 2-3 years after the index procedure. Moreover, there is no standard treatment for ISR, and although many options are available, there is still limited data regarding its optimal management. We report a paradigmatic case report of a patient complaining of symptomatic peripheral arterial disease, underwent multiple endovascular revascularizations for recurrent femoro-popliteal ISR. A step-by-step approach was followed. At the time of the first presentation, the ISR was treated by drug-eluting balloon (DEB) angioplasty. The repeated ISR was treated by laser debulking, achieving a good angiographic result. Finally, after the third repeated restenosis, a combined approach with laser debulking and DEB angioplasty guaranteed a good acute angiographic result. Long-term duplex-scan follow-up demonstrated the good patency of the femoro-popliteal target lesion.
Keyphrases
- case report
- newly diagnosed
- neoadjuvant chemotherapy
- end stage renal disease
- ejection fraction
- chronic kidney disease
- computed tomography
- liver failure
- high speed
- aortic dissection
- electronic health record
- minimally invasive
- prognostic factors
- radiation therapy
- big data
- squamous cell carcinoma
- artificial intelligence
- hepatitis b virus
- acute coronary syndrome
- percutaneous coronary intervention
- smoking cessation